Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
Date | Form | Description | Docs | XBRL | Pages |
01/29/14 | 8-K | Current report filing |
![]() ![]() |
5 | |
01/28/14 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
18 | |
01/24/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
![]() ![]() |
79 | |
01/24/14 | 8-K | Current report filing |
![]() ![]() |
46 | |
01/23/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
![]() ![]() |
79 | |
01/22/14 | 8-K | Current report filing |
![]() ![]() |
3 | |
01/14/14 | 8-K | Current report filing |
![]() ![]() |
3 | |
01/08/14 | EFFECT | Notice of Effectiveness |
![]() ![]() |
1 | |
01/07/14 | 8-K | Current report filing |
![]() ![]() |
33 | |
01/06/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
![]() ![]() |
1 |